Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to MOLECULAR THERAPEUTICS, INC. for $939,801.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI056850-01 | Phase I | 939,801 | ||||||||
A SBIR Phase I contract was awarded to MOLECULAR THERAPEUTICS, INC. for $183,548.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA091724-01A1 | Phase I | 183,548 | ||||||||
A SBIR Phase I contract was awarded to MOLECULAR THERAPEUTICS, INC. for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA096031-01 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to MOLECULAR THERAPEUTICS, INC. for $139,999.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA100976-01 | Phase I | 139,999 | ||||||||
A SBIR Phase I contract was awarded to MOLECULAR THERAPEUTICS, INC. for $398,392.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA119578-01A1 | Phase I | 398,392 | ||||||||
A SBIR Phase I contract was awarded to MOLECULAR THERAPEUTICS, INC. from the U.S. Department of Health & Human Services. | SBIR | 2R44CA091448-02 | Phase I | 0 | ||||||||
A SBIR Phase I contract was awarded to MOLECULAR THERAPEUTICS, INC. for $100,100.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AT002843-01 | Phase I | 100,100 | ||||||||
A SBIR Phase I contract was awarded to MOLECULAR THERAPEUTICS, INC. for $99,999.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DE015728-01A2 | Phase I | 99,999 | ||||||||
A SBIR Phase II contract was awarded to MOLECULAR THERAPEUTICS, INC. for $1,975,225.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA091448-02 | Phase II | 1,975,225 | ||||||||
A SBIR Phase I contract was awarded to MOLECULAR THERAPEUTICS, INC. for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 100,000 |